Physician profile
Michael Jonathan Clark
NPI 1619134970
$1,805.99
in general payments reported to CMS, 2019-2025
13 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $48.83 · 2021: $167 · 2022: $408 · 2023: $59.23 · 2024: $658 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,069.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $407.84 | 2022-2025 | Inspire |
| Medtronic, INC. | $376.57 | 2024-2025 | Pteye Parathyroid Detection System, Fusion, Propel |
| Genzyme Corporation | $252.31 | 2024-2025 | |
| Stryker Corporation | $235.21 | 2021-2022 | |
| Cochlear Americas | $147.45 | 2019-2020 | |
| Optinose US, INC. | $126.55 | 2020-2025 | |
| Aerin Medical INC. | $77.03 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $58.63 | 2023-2025 | Dupixent |
| Glaxosmithkline, LLC. | $42.36 | 2021-2024 | Nucala |
| Baxter Healthcare | $35.25 | 2024 | Perclot |
| Advanced Bionics, LLC | $17.21 | 2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Smith+Nephew, INC. | $15.41 | 2024 | Tula |
| Mvp Orthopedics INC | $14.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.